A case series of children and young people admitted to a tertiary care hospital in Germany with COVID-19.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
01 Feb 2021
Historique:
received: 12 08 2020
accepted: 11 01 2021
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 16 2 2021
Statut: epublish

Résumé

While our knowledge about COVID-19 in adults has rapidly increased, data on the course of disease and outcome in children with different comorbidities is still limited. Prospective, observational study at a tertiary care children's hospital in southern Germany. Clinical and virology data from all paediatric patients admitted with SARS-CoV-2 infection at our hospital were prospectively assessed. Between March and November 2020, 14 patients were admitted with COVID-19. One patient was admitted a second time with COVID-19 6 months after initial disease. Among seven patients with severe underlying comorbidities, three developed multisystem inflammatory syndrome (MIS-C), two were admitted to the paediatric intensive care unit. One patient needed invasive ventilation. Another patient died shortly after discharge of COVID-19-related complications. While COVID-19 generally causes mild disease in children, severe respiratory illness and MIS-C occur, in some cases with fatal outcome. Children with underlying diseases might be at special risk for severe disease.

Sections du résumé

BACKGROUND BACKGROUND
While our knowledge about COVID-19 in adults has rapidly increased, data on the course of disease and outcome in children with different comorbidities is still limited.
METHODS METHODS
Prospective, observational study at a tertiary care children's hospital in southern Germany. Clinical and virology data from all paediatric patients admitted with SARS-CoV-2 infection at our hospital were prospectively assessed.
RESULTS RESULTS
Between March and November 2020, 14 patients were admitted with COVID-19. One patient was admitted a second time with COVID-19 6 months after initial disease. Among seven patients with severe underlying comorbidities, three developed multisystem inflammatory syndrome (MIS-C), two were admitted to the paediatric intensive care unit. One patient needed invasive ventilation. Another patient died shortly after discharge of COVID-19-related complications.
CONCLUSIONS CONCLUSIONS
While COVID-19 generally causes mild disease in children, severe respiratory illness and MIS-C occur, in some cases with fatal outcome. Children with underlying diseases might be at special risk for severe disease.

Identifiants

pubmed: 33522901
doi: 10.1186/s12879-021-05791-8
pii: 10.1186/s12879-021-05791-8
pmc: PMC7848863
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

133

Références

Orbit. 2020 Aug;39(4):305-310
pubmed: 32419568
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet Infect Dis. 2020 Jul 24;:
pubmed: 32717206
Cell. 2020 Dec 23;183(7):1901-1912.e9
pubmed: 33248470
Lancet Psychiatry. 2020 Oct;7(10):875-882
pubmed: 32593341
Crit Rev Oncol Hematol. 2020 Sep;153:103059
pubmed: 32711241
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
Pediatr Infect Dis J. 2020 Jun;39(6):469-477
pubmed: 32398569
Eur J Pediatr. 2020 Oct 13;:
pubmed: 33051714
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
EClinicalMedicine. 2020 Jun 26;24:100433
pubmed: 32766542
Science. 2020 Dec 11;370(6522):1339-1343
pubmed: 33159009
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Dtsch Arztebl Int. 2020 May 22;117(21):373-374
pubmed: 32519943
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426
pubmed: 32271728
R I Med J (2013). 2020 Nov 9;103(10):24-26
pubmed: 33172223
J Pediatr. 2020 Nov 14;:
pubmed: 33197493
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):622-625
pubmed: 32951037
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Acta Paediatr. 2020 Jul;109(7):1497-1498
pubmed: 32279351
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
AJNR Am J Neuroradiol. 2020 Aug;41(8):1384-1387
pubmed: 32554425
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687
pubmed: 32352535
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

Jonathan Remppis (J)

Department of Haematology and Oncology, University Children's Hospital Tuebingen, Hoppe-Seyler-Straße 1, 72076, Tuebingen, Germany. jonathan.remppis@med.uni-tuebingen.de.

Tina Ganzenmueller (T)

Institute for Medical Virology, University Hospital Tuebingen, Elfriede-Aulhorn-Str. 6, 72076, Tuebingen, Germany.

Malte Kohns Vasconcelos (M)

Institute for Medical Microbiology and Hospital Hygiene, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Oliver Heinzel (O)

Department of Haematology and Oncology, University Children's Hospital Tuebingen, Hoppe-Seyler-Straße 1, 72076, Tuebingen, Germany.

Rupert Handgretinger (R)

Department of Haematology and Oncology, University Children's Hospital Tuebingen, Hoppe-Seyler-Straße 1, 72076, Tuebingen, Germany.

Hanna Renk (H)

Department of Haematology and Oncology, University Children's Hospital Tuebingen, Hoppe-Seyler-Straße 1, 72076, Tuebingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH